DuPont de Nemours, Inc. (DD) released its fourth‑quarter and full‑year 2025 financial results on February 10, 2026, reporting net sales of $1.693 billion for Q4 and $6.849 billion for the year, up 2 % year‑over‑year. The company posted an adjusted earnings per share of $0.46 for Q4 and $1.68 for the full year, exceeding consensus estimates and marking a 16 % increase in adjusted EPS year‑over‑year.
Operating earnings before interest, taxes, depreciation and amortization (EBITDA) rose to $409 million in Q4 and $1.628 billion for the year, reflecting a 4 % increase in Q4 and a 6 % increase for the full year. Segment results showed Healthcare & Water Technologies generating $821 million in net sales and $255 million in operating EBITDA, while Diversified Industrials produced $872 million in sales and $197 million in EBITDA, both segments maintaining margin stability amid a weak construction market.
For 2026, DuPont guided to net sales of approximately $1.670 billion in Q1 and $7.075 billion for the full year, with adjusted EPS of $0.48 in Q1 and $2.25–$2.30 for the year. The company reiterated its target of 3–4 % organic growth and 150–200 basis‑point margin expansion, underscoring confidence in its post‑separation portfolio and the impact of the $4.2 billion cash infusion from the Qnity separation.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.